Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma

Renal medullary carcinoma (RMC) is one of the most aggressive renal cell carcinomas. It predominantly afflicts young adults and adolescents with sickle cell trait and other sickle hemoglobinopathies, and is refractory to targeted and anti-angiogenic therapies used in patients with clear-cell renal c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Genitourin Cancer
Main Authors: Msaouel, Pavlos, Hong, Andrew L., Mullen, Elizabeth A., Atkins, Michael B., Walker, Cheryl Lyn, Lee, Chung-Han, Carden, Marcus A., Genovese, Giannicola, Linehan, W. Marston, Rao, Priya, Merino, Maria J., Grodman, Howard, Dome, Jeffrey S., Fernandez, Conrad V., Geller, James I., Apolo, Andrea B., Daw, Najat C., Hodges, H. Courtney, Moxey-Mims, Marva, Wei, Darmood, Bottaro, Donald P., Staehler, Michael, Karam, Jose A., Rathmell, W. Kimryn, Tannir, Nizar M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348017/
https://ncbi.nlm.nih.gov/pubmed/30287223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2018.09.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados